Endo (NDOI) Net Margin % : 0.00% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Endo Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Endo's Net Income for the three months ended in Dec. 2024 was $0 Mil. Endo's Revenue for the three months ended in Dec. 2024 was $0 Mil. Therefore, Endo's net margin for the quarter that ended in Dec. 2024 was 0.00%.

The historical rank and industry rank for Endo's Net Margin % or its related term are showing as below:

NDOI' s Net Margin % Range Over the Past 10 Years
Min: -126.06 Med: -123.93 Max: 245.59
Current: 245.59

NDOI's Net Margin % is ranked better than
99.08% of 979 companies
in the Drug Manufacturers industry
Industry Median: 4.59 vs NDOI: 245.59

Endo Net Margin % Historical Data

The historical data trend for Endo's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Net Margin % Chart

Endo Annual Data

Trend

Dec22

Dec23

Dec24

Net Margin %

-126.06

-121.79

Endo Quarterly Data
	Jun23	Sep23	Dec23	Apr24	Sep24	Dec24
Net Margin %	Get a 7-Day Free Trial			-6.31	-490.52	1,095.12	-54.58	-

Competitive Comparison of Endo's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Endo's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endo's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo's Net Margin % distribution charts can be found below:

* The bar in red indicates where Endo's Net Margin % falls into.

Save Embed

;

Save Embed

;

Endo Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Endo's Net Margin for the fiscal year that ended in Dec. 2024 is calculated as

Net Margin	=	Net Income (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	0	/	0
	=	%

Endo's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin	=	Net Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0	/	0
	=	%

Endo (OTCPK:NDOI) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Endo Net Margin % Related Terms

Thank you for viewing the detailed overview of Endo's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

9 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.endo.com

Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.